Acute Bronchitis: Evidence‑Based Definition, Diagnosis, and Management

Definition and Epidemiology

• Acute bronchitis is a self‑limited acute respiratory infection characterized by cough (with or without sputum) lasting ≤ 3 weeks and lacking clinical or radiographic evidence of pneumonia. The American College of Chest Physicians defines it this way. [1][2]
• The condition reflects acute inflammation of the large airways (bronchi) and may be accompanied by mild constitutional symptoms. The American College of Chest Physicians. 3
• Respiratory viruses are responsible for > 90 % of acute bronchitis episodes, whereas bacterial pathogens account for < 10 % of cases. The American College of Chest Physicians. 3
• When cough persists beyond 3 weeks, clinicians should consider alternative diagnoses such as post‑infectious cough, upper‑airway cough syndrome, asthma, or gastro‑esophageal reflux disease. The American College of Chest Physicians. [1][2]

Diagnostic Approach

Excluding Pneumonia

• The primary diagnostic task is to rule out pneumonia, because its presence dictates the need for targeted antimicrobial therapy. The American College of Chest Physicians. 4
• In otherwise healthy adults < 70 years, pneumonia is highly unlikely when all of the following are absent: heart rate < 100 bpm, respiratory rate < 24 breaths/min, oral temperature < 38 °C, and normal chest examination (no focal consolidation, rales, egophony, or tactile fremitus). The American College of Chest Physicians. 3

Key Differential Diagnoses to Exclude

• Common cold – predominance of upper‑respiratory symptoms (nasal congestion, discharge, sneezing, sore throat). The American College of Chest Physicians. 2
• Acute asthma or COPD exacerbation – approximately one‑third of patients presenting with acute cough have underlying asthma that is often misdiagnosed as bronchitis. The American College of Chest Physicians. 2
• Pertussis – should be considered when cough lasts > 2–3 weeks with paroxysmal features, whooping, or post‑tussive emesis. The American College of Chest Physicians. 2

Recurrent “Bronchitis” Suggests Underlying Asthma

• Among patients with ≥ 2 similar episodes of “acute bronchitis” in the prior 5 years, about 65 % actually have underlying mild asthma. The American College of Chest Physicians. 2

Sputum Color Is Not a Bacterial Marker

• Purulent or green/yellow sputum does not indicate bacterial infection; the coloration reflects inflammatory cells and sloughed epithelium rather than bacterial presence. The American College of Chest Physicians. 3

Tests Not Routinely Indicated

• Routine viral PCR testing, C‑reactive protein or procalcitonin measurement, and complete blood count do not improve management of acute bronchitis and are therefore not recommended. The American College of Chest Physicians. 2

Management

Antibiotic Stewardship

• Antibiotics should not be prescribed routinely for acute bronchitis. Evidence shows only a modest benefit (≈ 0.5 day reduction in cough duration) and exposes patients to adverse effects and antimicrobial resistance. The American College of Chest Physicians (strong recommendation). [1][5]3

Therapies Lacking Efficacy

• Expectorants and mucolytic agents have no consistent favorable effect and are not recommended. The American College of Chest Physicians. 5
• Routine oral non‑steroidal anti‑inflammatory drugs (NSAIDs) do not improve outcomes and are not advised. The American College of Chest Physicians. 2

Symptomatic Relief

• Antitussive agents may be offered occasionally for short‑term relief (Grade C recommendation). The American College of Chest Physicians. 5

Management of Confirmed or Suspected Pertussis

• Prescribe a macrolide antibiotic (e.g., azithromycin, clarithromycin, or erythromycin). The American College of Chest Physicians. [1][5]
• Isolate the patient for 5 days from the start of treatment. The American College of Chest Physicians. 5
• Initiating therapy within the first few weeks reduces cough paroxysms and limits disease spread; benefit diminishes after this early period. The American College of Chest Physicians. [1][5]

Follow‑Up and Reassessment

• Patients should be reassessed if cough persists beyond 3 weeks, prompting evaluation for alternative diagnoses. The American College of Chest Physicians. 1

Clinical Pitfalls to Avoid

• Do not base antibiotic decisions on sputum color or purulence. The American College of Chest Physicians. 3
• Do not label a patient with acute bronchitis when cough exceeds 3 weeks; instead, investigate other etiologies. The American College of Chest Physicians. [1][2]
• Do not overlook underlying asthma in individuals with recurrent “bronchitis” episodes. The American College of Chest Physicians. 2
• Do not confuse acute bronchitis with common cold, asthma exacerbation, or COPD exacerbation. The American College of Chest Physicians. [4][2]

Acute Bronchitis – Evidence‑Based Guideline Summary

Epidemiology & Etiology

• Respiratory viruses are responsible for >90 % of acute bronchitis episodes, with bacterial infection accounting for fewer than 10 % of cases. [6][7]8

Diagnosis

Diagnostic Criteria & Initial Evaluation

• Acute bronchitis is defined by an acute cough (with or without sputum) lasting < 3 weeks in the absence of clinical or radiographic evidence of pneumonia. [6][9]
• Excluding pneumonia is the primary diagnostic step; clinicians should first assess for signs suggestive of pneumonia. [10][11]

Clinical Findings That Make Pneumonia Unlikely (Adults < 70 years, otherwise healthy)

• Absence of all the following: heart rate ≥ 100 beats/min, respiratory rate ≥ 24 breaths/min, oral temperature ≥ 38 °C, and abnormal chest‑exam findings (rales, egophony, tactile fremitus, focal consolidation). When all are absent, pneumonia is unlikely. [10][12]8
• Individual thresholds:
  
  • HR ≥ 100 beats/min – associated with higher pneumonia risk. 9
  • RR ≥ 24 breaths/min – associated with higher pneumonia risk. 9
  • Temperature ≥ 38 °C – associated with higher pneumonia risk. 13
  • Abnormal chest auscultation (rales, egophony, etc.) – associated with higher pneumonia risk. 9

Imaging

• Chest radiography is not required when vital signs are normal and lung examination shows no focal findings. [10][11]

Differential Diagnosis to Exclude Before Labeling Acute Bronchitis

• Common cold (predominantly upper‑respiratory symptoms). 9
• Acute asthma or COPD exacerbation. 7
• Pneumonia (using the clinical criteria above). 9
• Pertussis (consider when cough > 2–3 weeks with paroxysmal features, whooping, or post‑tussive emesis). 7

Laboratory & Ancillary Tests (Not Routinely Indicated)

• Chest X‑ray (unless abnormal vitals or exam). 10
• Spirometry or peak flow measurement. 14
• Sputum culture. 9
• Viral PCR testing. 6
• C‑reactive protein or procalcitonin. 14
• Complete blood count. 14

Sputum Characteristics

• Purulent or green/yellow sputum does not indicate bacterial infection; the color reflects inflammatory cells and sloughed epithelium rather than bacterial presence. [10][15]12

Management

Pharmacologic Therapy – What Not to Prescribe Routinely

• Antibiotics: no meaningful benefit (≈ 0.5 day reduction in cough) and increase adverse effects and resistance. [6][7][14][8]
• Inhaled β‑agonists and anticholinergics: evidence does not support routine use. 14
• Oral NSAIDs: no proven advantage for cough resolution. 14
• Expectorants: no demonstrated efficacy. 6

Symptomatic & Supportive Care

• Patient education is the cornerstone: explain that cough typically persists 2–3 weeks, label the illness as a “chest cold” to lower antibiotic expectations, and emphasize that communication quality drives satisfaction more than prescriptions. [16][10]11
• Albuterol may be trialed when wheezing or bothersome cough is present; about 50 % of patients report cough improvement by day 7 of therapy. 16
• Environmental modifications (removing dust/dander, using humidified air in dry settings) can reduce cough triggers. 16

Follow‑Up & Reassessment Criteria

• Return for evaluation if cough exceeds 3 weeks, suggesting alternative diagnoses such as post‑infectious cough, upper‑airway cough syndrome, asthma, or GERD. [14][6]7
• Seek care sooner if symptoms worsen, prompting targeted investigations (repeat chest X‑ray, sputum culture, peak flow, CBC, inflammatory markers). 14
• Immediate reassessment is warranted for new fever, tachypnea, or abnormal vital signs indicative of possible pneumonia. 13

Special Situations

Pertussis

• If pertussis is confirmed or highly suspected, prescribe a macrolide (azithromycin, clarithromycin, or erythromycin). 7
• Isolate the patient for 5 days from the start of therapy. 7
• Early macrolide treatment (within the first few weeks) reduces cough paroxysms and transmission; benefit diminishes after this period. 7

Influenza (During Flu Season)

• Consider antiviral therapy (e.g., oseltamivir) within 48 hours of symptom onset per CDC guidance; this can lower antibiotic use, reduce hospitalizations, and improve outcomes. 13

Common Pitfalls to Avoid

• Do not base antibiotic decisions on sputum color or purulence. [10][15]12
• Do not label a patient with acute bronchitis when cough persists > 3 weeks; investigate other etiologies. [6][7]9
• Do not miss underlying asthma: among patients with ≥ 2 similar “acute bronchitis” episodes in the prior 5 years, ~ 65 % have mild asthma. [9][14]

All facts are derived from peer‑reviewed evidence with citation identifiers as indicated.

Systemic Corticosteroids Are Not Indicated for Uncomplicated Acute Bronchitis

Epidemiology and Natural History

Guideline Recommendations

Lack of Benefit and Potential Harm

Diagnostic Considerations

Rule Out Pneumonia

Consider Asthma or COPD Exacerbation

Management Recommendations

Uncomplicated Acute Bronchitis

When Steroids Are Indicated (Asthma or COPD Exacerbation)

Practical Pitfalls to Avoid